dihexa chemical properties solubility stability formulation (PNB-0408) | c-Met/HGFR Activator As part of its strategy
As part of its strategy to explore additional delivery systems for MEAI, Clearmind initiated formulation feasibility studies to evaluate the compound's suitability for intranasal administration. Initial work focused on evaluating MEAI's compatibility with DIHEXA HGF Mimetic Hexapeptide, Lab Tested DIHEXA Peptide Synthetic High Purity ProSpec Formulation Strategies to Enhance the Solubility of Poorly Water Soluble Drugs and Phytochemicals: Current Advances and Challenges Solubility Enhancement of Dihydroquercetin via Green Phase Modification
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



